BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cellsMarie-Magdelaine Coudé, Claude Gardin, Thorsten Braun et al.|Oncotarget|2015Cited by 272
A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancersFilippo Spriano, Francesco Bertoni, Giulio Sartori et al.|Haematologica|2024Cited by 5
Supplementary Figure 5. from Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton G. Henssen, Johannes H. Schulte, Kristina Althoff et al.|Unknown|2023Cited by 0
Differentially expressed genes OTX015 JQ1 from Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton G. Henssen, Johannes H. Schulte, Kristina Althoff et al.|Unknown|2023Cited by 0
All genes Hg19_BRD4_OTX from Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton G. Henssen, Johannes H. Schulte, Kristina Althoff et al.|Unknown|2023Cited by 0